We postulated that the activation of TLR7 at the onset of infection can boost early antiviral IFN responses for protection against the virus while inhibiting TLR7 once an infection is established could suppress the cytokine storm and inflammatory lung damage. The gene discussed is IFNA1; the disease is infection.